Amgen Stock - Thursday chart snapshot around key support
18.06.2026 - 21:17:46 | ad-hoc-news.de
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 19:16 UTC. Details in the imprint.
Amgen (US0311621009) is trading below its recent peak on the Nasdaq this Thursday. The large-cap biotech stock is moving in a relatively narrow range intraday while technical traders watch support and resistance levels to gauge near-term momentum.
All news and background on Amgen stock
Key data, regulatory filings and recent headlines help frame how Amgen trades on Nasdaq and how investors interpret new information.
What Thursday’s chart shows
On Thursday, Amgen shares trade around the mid-$330s, below a recent close of $341.66 cited earlier this week, when the stock declined 1.78% in a single session according to Zacks. Zacks highlights that move relative to the broader market.
Intraday data show the stock recently changing hands near $336, marking a modest pullback from short-term highs but still well above its 52-week low. Trading volumes remain within a normal range for a Standard & Poor's 500 index constituent.
Key technical markers in focus
Recent quotes indicate Amgen shares are fluctuating modestly below an indicated analyst average price target around $359, underscoring a gap between current trading levels and aggregated sell-side expectations. TradingKey data show a consensus target near $359.56.
From a chart perspective, market participants often watch the 50-day and 200-day moving averages as trend lines, as well as the area around recent swing highs above $340, to assess whether momentum is stabilizing or softening after a strong first half.
The product behind the stock
Amgen generates most of its revenue from branded biologic therapies, including its cholesterol drug Repatha and osteoporosis treatment Prolia, alongside a growing biosimilars portfolio in oncology and immunology that broadens its global footprint.
Where the stock trades today
The shares of Amgen (US0311621009) trade on the Nasdaq at about $336 per share as of 06/18/2026, 19:00 UTC.
Key facts on Amgen stock
- Company: Amgen Inc.
- ISIN: US0311621009
- WKN: 867900
- Ticker: AMGN
- Venue: Nasdaq
- Price (as of 06/18/2026, 19:00 UTC): 336.00 USD
- Market cap: 181,000,000,000 USD (as of 06/18/2026)
- Sector / Industry: Health Care / Biotechnology
- Index membership: S&P 500
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
